JP Morgan Private Wealth Advisors’s Halozyme HALO Stock Holding History

JP Morgan Private Wealth Advisors’s Portfolio HALO Stock Details HALO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	$509K	Sell	13,323 -8,815	-40%	-$361K	﹤0.01%	1240
2023 Q2	$799K	Sell	22,138 -107,269	-83%	-$3.66M	﹤0.01%	846
2023 Q1	$4.94M	Sell	129,407 -22,326	-15%	-$1.05M	0.01%	587
2022 Q4	$8.63M	Sell	151,733 -11,761	-7%	-$602K	0.02%	453
2022 Q3	$6.46M	Buy	163,494 +3,752	+2%	+$166K	0.02%	495
2022 Q2	$7.03M	Sell	159,742 -47,208	-23%	-$2.04M	0.02%	491
2022 Q1	$8.25M	Buy	206,950 +3,493	+2%	+$124K	0.02%	492
2021 Q4	$8.18M	Buy	203,457 +39,185	+24%	+$1.46M	0.02%	487
2021 Q3	$6.68M	Sell	164,272 -20,810	-11%	-$870K	0.02%	522
2021 Q2	$8.4M	Buy	185,082 +93,562	+102%	+$4.14M	0.02%	455
2021 Q1	$3.81M	Buy	91,520 +2,896	+3%	+$132K	0.01%	576
2020 Q4	$3.79M	Buy	88,624 +7,917	+10%	+$285K	0.01%	561
2020 Q3	$2.12M	Buy	80,707 +256	+0.3%	+$7.13K	0.01%	636
2020 Q2	$2.16M	Buy	80,451 +37,014	+85%	+$835K	0.01%	565
2020 Q1	$781K	Hold	43,437	–	–	﹤0.01%	790
2019 Q4	$770K	Buy	43,437 +970	+2%	+$16.8K	﹤0.01%	891
2019 Q3	$659K	Buy	42,467 +431	+1%	+$7.1K	﹤0.01%	917
2019 Q2	$722K	Buy	42,036 +36	+0.1%	+$581	﹤0.01%	859
2019 Q1	$676K	Hold	42,000	–	–	﹤0.01%	915
2018 Q4	$614K	Sell	42,000 -736	-2%	-$11.7K	﹤0.01%	893
2018 Q3	$777K	Hold	42,736	–	–	﹤0.01%	913
2018 Q2	$721K	Sell	42,736 -2,275	-5%	-$43K	﹤0.01%	883
2018 Q1	$882K	Buy	45,011 +11	+0%	+$213	0.01%	678
2017 Q4	$912K	Buy	45,000 +3,000	+7%	+$55.2K	0.01%	686
2017 Q3	$730K	Hold	42,000	–	–	0.01%	713
2017 Q2	$538K	Hold	42,000	–	–	﹤0.01%	815
2017 Q1	$544K	Hold	42,000	–	–	﹤0.01%	816
2016 Q4	$415K	Hold	42,000	–	–	﹤0.01%	871
2016 Q3	$507K	Hold	42,000	–	–	﹤0.01%	782
2016 Q2	$362K	Hold	42,000	–	–	﹤0.01%	898
2016 Q1	$398K	Sell	42,000 -12,025	-22%	-$113K	﹤0.01%	827
2015 Q4	$936K	Buy	54,025 +11,025	+26%	+$176K	0.01%	541
2015 Q3	$577K	Buy	43,000 +995	+2%	+$20K	0.01%	576
2015 Q2	$948K	Sell	42,005 -45	-0.1%	-$791	0.01%	514
2015 Q1	$600K	Sell	42,050 -1,200	-3%	-$17.3K	0.01%	662
2014 Q4	$417K	Buy	43,250 +1,250	+3%	+$11.1K	0.01%	779
2014 Q3	$382K	Hold	42,000	–	–	﹤0.01%	774
2014 Q2	$415K	Hold	42,000	–	–	0.01%	620
2014 Q1	$534K	Hold	42,000	–	–	0.01%	547
2013 Q4	$630K	Hold	42,000	–	–	0.01%	410
2013 Q3	$464K	Hold	42,000	–	–	0.01%	449
2013 Q2	$334K	Buy	+42,000	New	+$267K	0.01%	480

Other funds holding HALO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

SCM

Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

JP Morgan Private Wealth Advisors's HALO Position: Q3 2023 in Review

JP Morgan Private Wealth Advisors reduced its Halozyme (HALO) stake by 40% in Q3 2023, selling an estimated $361K and leaving 13,323 shares worth $509K. The position accounts for ﹤0.01% of the portfolio, ranked #1240.

JP Morgan Private Wealth Advisors first reported a position in HALO in Q2 2013 and has held it in 42 quarters since. The position peaked at $8.63M in Q4 2022. 389 funds tracked by Wall St. Rank hold HALO as of Q3 2023.

JP Morgan Private Wealth Advisors held 13,323 shares of Halozyme worth $509K as of Q3 2023.
JP Morgan Private Wealth Advisors sold 8,815 Halozyme shares in Q3 2023, an estimated $361K.
Halozyme made up ﹤0.01% of JP Morgan Private Wealth Advisors's portfolio in Q3 2023, its #1240 holding.
JP Morgan Private Wealth Advisors first reported a position in Halozyme in Q2 2013 and has held it in 42 quarters since.
JP Morgan Private Wealth Advisors's Halozyme position peaked at $8.63M in Q4 2022.
389 funds tracked by Wall St. Rank held Halozyme as of Q3 2023.

Based on JP Morgan Private Wealth Advisors's 13F filing for Q3 2023, filed 8 Nov 2023.